Amyris Buys Ingredion’s Stake in the Real Sweet Joint Venture

Amyris and Ingredion Incorporated (NYSE:INGR) have agreed to end their RealSweet joint venture.

A close up of a baker stirring a bowl of flour and sugar in a bakery.

Amyris will take complete control of the Precision Fermentation Plant in Barra Bonita, Brazil, as part of the new agreement. As a result, Ingredion Incorporated (NYSE:INGR) is granted exclusive access to Amyris’ fermented Reb M technology for production and marketing, setting the stage for future collaboration. Both businesses will benefit from improved operational focus and commercial clarity as an outcome of the strategic pivot.

Amyris, a synthetic biology pioneer, will fully oversee its Brazilian laboratory, strengthening its vertically integrated approach. Sustainable components used in products all around the world are produced by the company’s in-house fermentation platform.

Ingredion Incorporated (NYSE:INGR), a worldwide ingredient producer with $7.4 billion in sales in 2024 and operations in more than 120 countries, will use its exclusive rights to fermented Reb M, a sugar substitute.

Through this collaboration, Amyris fortifies its core production capabilities for future expansion, while Ingredion expands its portfolio of functional sweeteners.

While we acknowledge the potential of INGR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than INGR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.